Actualités
Publications de nos équipes - avril 2012
Long-Term Analysis of the IFM 99 Trials for Myeloma : Cytogenetic Abnormalities [t(4 ;14), del(17p), 1q gains] Play...Publié le 10-05-2012
>> Lire plus...
Publications de nos équipes - Mars 2012
p27Kip1 controls cytokinesis via the regulation of citron kinase activation. Serres MP, Kossatz U, Chi Y, Roberts...Publié le 03-04-2012
>> Lire plus...
Pole de recherche hospitalo-universitaire CAPTOR
Le projet CAPTOR (Cancer Pharmacology of Toulouse and Region ) a été labellisé par l’ANR , dans le cadre des...Publié le 22-03-2012
>> Lire plus...
Publications de nos équipes - Février 2012
Size control of the Drosophila hematopoietic niche by bone morphogenetic protein signaling reveals parallels with...Publié le 05-03-2012
>> Lire plus...
Labex Toucan
Le projet Toucan a été labellisé dans le cadre de l’appel d’offre Labex (Laboratoire d’excellence). Félicitations au...Publié le 22-02-2012
>> Lire plus...
>> Toutes les actualités
Les équipes > Actualités équipes
Publications de décembre 2009
NAD(P)H quinone-oxydoreductase 1 (NQO1) protects eIF4GI from degradation by the proteasome. Alard A, Fabre B, Anesia R, Marboeuf C, Pierre P, Susini C, Bousquet C, Pyronnet S. Mol Cell Biol. 2009 Dec 22. PMID : 20028737
Evolutionary Conserved Function of RRP36 in Early Cleavages of the Pre-ribosomal RNA and Production of the 40S Ribosomal Subunit. Gérus M, Bonnart C, Caizergues-Ferrer M, Henry Y, Henras AK. Mol Cell Biol. 2009 Dec 28. PMID : 20038530
The ATPase and helicase activities of Prp43p are stimulated by the G-patch protein Pfa1p during yeast ribosome biogenesis. Lebaron S, Papin C, Capeyrou R, Chen YL, Froment C, Monsarrat B, Caizergues-Ferrer M, Grigoriev M, Henry Y. EMBO J. 2009 Dec 16 ;28(24):3808-19.
Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation. Colié S, Van Veldhoven PP, Kedjouar B, Bedia C, Albinet V, Sorli SC, Garcia V, Djavaheri-Mergny M, Bauvy C, Codogno P, Levade T, Andrieu-Abadie N. Cancer Res. 2009 Dec 15 ;69(24):9346-53.
Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy : long-term analysis of the IFM 99-02 and 99-04 Trials. Harousseau JL, Avet-Loiseau H, Attal M, Charbonnel C, Garban F, Hulin C, Michallet M, Facon T, Garderet L, Marit G, Ketterer N, Lamy T, Voillat L, Guilhot F, Doyen C, Mathiot C, Moreau P. J Clin Oncol. 2009 Dec 1 ;27(34):5720-6.
Replacement of Imu-Cmu intron by NeoR gene alters Imu germ-line expression but has no effect on V(D)J recombination. Haddad D, Dougier HL, Laviolette N, Puget N, Khamlichi AA. Mol Immunol. 2009 Dec 25.
Interaction of the HIV-1 frameshift signal with the ribosome. Mazauric MH, Seol Y, Yoshizawa S, Visscher K, Fourmy D. Nucleic Acids Res. 2009 Dec ;37(22):7654-64.
Molecular mechanisms of eukaryotic pre-mRNA 3’ end processing regulation. Millevoi S, Vagner S. Nucleic Acids Res. 2009 Dec 30. PMID : 20044349
Trastuzumab for patients with axillary-node-positive breast cancer : results of the FNCLCC-PACS 04 trial. Spielmann M, Roché H, Delozier T, Canon JL, Romieu G, Bourgeois H, Extra JM, Serin D, Kerbrat P, Machiels JP, Lortholary A, Orfeuvre H, Campone M, Hardy-Bessard AC, Coudert B, Maerevoet M, Piot G, Kramar A, Martin AL, Penault-Llorca F. J Clin Oncol. 2009 Dec 20 ;27(36):6129-34.
Soft Lithographic Patterning of Spin Crossover Nanoparticles. Thibault C, Molnár G, Salmon L, Bousseksou A, Vieu C. Langmuir. 2009 Dec 2. PMID : 19950983
Where does hydrogen adsorb on Ru nanoparticles ? A powerful joint (2)H MAS-NMR/DFT approach.Tru Andier LA, Del Rosal I, Chaudret B, Poteau R, Gerber IC. Chemphyschem. 2009 Dec 7 ;10(17):2939-42.
3D imaging of the response to CDC25 inhibition in multicellular spheroids. Frongia C, Lorenzo C, Gianni F, Prevost GP, Ducommun B, Lobjois V. Cancer Biol Ther. 2009 Dec 3 ;8(23).
Pivotal role of translokin/CEP57 in the unconventional secretion versus nuclear translocation of FGF2. Meunier S, Navarro MG, Bossard C, Laurell H, Touriol C, Lacazette E, Prats H. Traffic. 2009 Dec ;10(12):1765-72. Epub 2009 Sep 14.PMID : 19804566
Factors predicting the sentinel node metastases in T1 breast cancer tumor : an analysis of 1416 cases. Capdet J, Martel P, Charitansky H, Lim YK, Ferron G, Battle L, Landier A, Mery E, Zerdoub S, Roche H, Querleu D. Eur J Surg Oncol. 2009 Dec ;35(12):1245-9.
Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism. Haurie V, Ménard L, Nicou A, Touriol C, Metzler P, Fernandez J, Taras D, Lestienne P, Balabaud C, Bioulac-Sage P, Prats H, Zucman-Rossi J, Rosenbaum J. Hepatology. 2009 Dec ;50(6):1871-83.
An organometallic approach for the synthesis of water-soluble ruthenium and platinum nanoparticles. Debouttière PJ, Martinez V, Philippot K, Chaudret B. Dalton Trans. 2009 Dec 14 ;(46):10172-4.
IRES-based vector coexpressing FGF2 and Cyr61 provides synergistic and safe therapeutics of lower limb ischemia. Rayssac A, Neveu C, Pucelle M, Van den Berghe L, Prado-Lourenco L, Arnal JF, Chaufour X, Prats AC. Mol Ther. 2009 Dec ;17(12):2010-9.
Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Sauer L, Nunes J, Salunkhe V, Skalska L, Kohama T, Cuvillier O, Waxman J, Pchejetski D. Int J Cancer. 2009 Dec 1 ;125(11):2728-36.
[Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer] Ferron G, Martinez A, Mery E, Querleu D, Thomas F, Chatelut E, Gladieff L. Bull Cancer. 2009 Dec ;96(12):1243-52. Review. French.
[Pharmacological bases of intraperitoneal chemotherapy] Gladieff L, Chatelut E, Dalenc F, Ferron G. Bull Cancer. 2009 Dec ;96(12):1235-42. Review. French.
5-Substituted [1]pyrindine derivatives with antiproliferative activity. Kolb S, Goddard ML, Loukaci A, Mondésert O, Ducommun B, Braud E, Garbay C. Eur J Med Chem. 2009 Dec 5. PMID : 19969400
[Management of advanced epithelial cancer of the ovary : towards a change in practice ?] Leblanc E, Narducci F, Querleu D, Morice P. Bull Cancer. 2009 Dec ;96(12):1149-50. French.
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. Legrand-Abravanel F, Colson P, Leguillou-Guillemette H, Alric L, Ravaux I, Lunel-Fabiani F, Bouviers-Alias M, Trimoulet P, Chaix ML, Hézode C, Foucher J, Fontaine H, Roque-Afonso AM, Gassin M, Schvoerer E, Gaudy C, Roche B, Doffoël M, D’Alteroche L, Vallet S, Baazia Y, Pozzetto B, Thibault V, Nousbaum JB, Roulot D, Coppere H, Poinard T, Payan C, Izopet J. J Med Virol. 2009 Dec ;81(12):2029-35.PMID : 19856464
Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients : results of the PACS 01 economic study. Marino P, Siani C, Roché H, Protière C, Fumoleau P, Spielmann M, Martin AL, Viens P, Le Corroller Soriano AG. Ann Oncol. 2009 Dec 27. PMID : 20038515
[Etiology and outcome of liver granulomatosis : A retrospective study of 21 cases.] Martin-Blondel G, Camara B, Selves J, Robic MA, Thebault S, Bonnet D, Alric L. Rev Med Interne. 2009 Dec 3. French. PMID : 19962798
Synthesis of new alkylaminooxysterols with potent cell differentiating activities : identification of leads for the treatment of cancer and neurodegenerative diseases. de Medina P, Paillasse MR, Payré B, Silvente-Poirot S, Poirot M. J Med Chem. 2009 Dec 10 ;52(23):7765-77.
French recommendations on the management of invasive cervical cancer during pregnancy. Morice P, Narducci F, Mathevet P, Marret H, Darai E, Querleu D ; French Working Group on Gynecological Cancers in Pregnancy ; Société Française d’Oncologie Gynécologique (SFOG) ; Société Française de Chirurgie Pelvienne (SFCP) ; Collège National des Gynécologues Obstétriciens Français (CNGOF). Int J Gynecol Cancer. 2009 Dec ;19(9):1638-41.
Association of neutrophil count with microembolization in patients with symptomatic carotid artery stenosis. Nasr N, Ruidavets JB, Arnal JF, Sie P, Larrue V. Atherosclerosis. 2009 Dec ;207(2):519-23.
[Towards a new standard in cytoreductive surgery for advanced ovarian cancer] Querleu D, Gladieff L, Ferron G, Rougé P. Bull Cancer. 2009 Dec ;96(12):1175-82. Review. French.
[Quality control criteria in the surgical management of advanced ovarian cancers] Querleu D, Narducci F. Bull Cancer. 2009 Dec ;96(12):1255-62. Review. French.
Evolutionary Conserved Function of RRP36 in Early Cleavages of the Pre-ribosomal RNA and Production of the 40S Ribosomal Subunit. Gérus M, Bonnart C, Caizergues-Ferrer M, Henry Y, Henras AK. Mol Cell Biol. 2009 Dec 28. PMID : 20038530
The ATPase and helicase activities of Prp43p are stimulated by the G-patch protein Pfa1p during yeast ribosome biogenesis. Lebaron S, Papin C, Capeyrou R, Chen YL, Froment C, Monsarrat B, Caizergues-Ferrer M, Grigoriev M, Henry Y. EMBO J. 2009 Dec 16 ;28(24):3808-19.
Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation. Colié S, Van Veldhoven PP, Kedjouar B, Bedia C, Albinet V, Sorli SC, Garcia V, Djavaheri-Mergny M, Bauvy C, Codogno P, Levade T, Andrieu-Abadie N. Cancer Res. 2009 Dec 15 ;69(24):9346-53.
Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy : long-term analysis of the IFM 99-02 and 99-04 Trials. Harousseau JL, Avet-Loiseau H, Attal M, Charbonnel C, Garban F, Hulin C, Michallet M, Facon T, Garderet L, Marit G, Ketterer N, Lamy T, Voillat L, Guilhot F, Doyen C, Mathiot C, Moreau P. J Clin Oncol. 2009 Dec 1 ;27(34):5720-6.
Replacement of Imu-Cmu intron by NeoR gene alters Imu germ-line expression but has no effect on V(D)J recombination. Haddad D, Dougier HL, Laviolette N, Puget N, Khamlichi AA. Mol Immunol. 2009 Dec 25.
Interaction of the HIV-1 frameshift signal with the ribosome. Mazauric MH, Seol Y, Yoshizawa S, Visscher K, Fourmy D. Nucleic Acids Res. 2009 Dec ;37(22):7654-64.
Molecular mechanisms of eukaryotic pre-mRNA 3’ end processing regulation. Millevoi S, Vagner S. Nucleic Acids Res. 2009 Dec 30. PMID : 20044349
Trastuzumab for patients with axillary-node-positive breast cancer : results of the FNCLCC-PACS 04 trial. Spielmann M, Roché H, Delozier T, Canon JL, Romieu G, Bourgeois H, Extra JM, Serin D, Kerbrat P, Machiels JP, Lortholary A, Orfeuvre H, Campone M, Hardy-Bessard AC, Coudert B, Maerevoet M, Piot G, Kramar A, Martin AL, Penault-Llorca F. J Clin Oncol. 2009 Dec 20 ;27(36):6129-34.
Soft Lithographic Patterning of Spin Crossover Nanoparticles. Thibault C, Molnár G, Salmon L, Bousseksou A, Vieu C. Langmuir. 2009 Dec 2. PMID : 19950983
Where does hydrogen adsorb on Ru nanoparticles ? A powerful joint (2)H MAS-NMR/DFT approach.Tru Andier LA, Del Rosal I, Chaudret B, Poteau R, Gerber IC. Chemphyschem. 2009 Dec 7 ;10(17):2939-42.
3D imaging of the response to CDC25 inhibition in multicellular spheroids. Frongia C, Lorenzo C, Gianni F, Prevost GP, Ducommun B, Lobjois V. Cancer Biol Ther. 2009 Dec 3 ;8(23).
Pivotal role of translokin/CEP57 in the unconventional secretion versus nuclear translocation of FGF2. Meunier S, Navarro MG, Bossard C, Laurell H, Touriol C, Lacazette E, Prats H. Traffic. 2009 Dec ;10(12):1765-72. Epub 2009 Sep 14.PMID : 19804566
Factors predicting the sentinel node metastases in T1 breast cancer tumor : an analysis of 1416 cases. Capdet J, Martel P, Charitansky H, Lim YK, Ferron G, Battle L, Landier A, Mery E, Zerdoub S, Roche H, Querleu D. Eur J Surg Oncol. 2009 Dec ;35(12):1245-9.
Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism. Haurie V, Ménard L, Nicou A, Touriol C, Metzler P, Fernandez J, Taras D, Lestienne P, Balabaud C, Bioulac-Sage P, Prats H, Zucman-Rossi J, Rosenbaum J. Hepatology. 2009 Dec ;50(6):1871-83.
An organometallic approach for the synthesis of water-soluble ruthenium and platinum nanoparticles. Debouttière PJ, Martinez V, Philippot K, Chaudret B. Dalton Trans. 2009 Dec 14 ;(46):10172-4.
IRES-based vector coexpressing FGF2 and Cyr61 provides synergistic and safe therapeutics of lower limb ischemia. Rayssac A, Neveu C, Pucelle M, Van den Berghe L, Prado-Lourenco L, Arnal JF, Chaufour X, Prats AC. Mol Ther. 2009 Dec ;17(12):2010-9.
Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Sauer L, Nunes J, Salunkhe V, Skalska L, Kohama T, Cuvillier O, Waxman J, Pchejetski D. Int J Cancer. 2009 Dec 1 ;125(11):2728-36.
[Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer] Ferron G, Martinez A, Mery E, Querleu D, Thomas F, Chatelut E, Gladieff L. Bull Cancer. 2009 Dec ;96(12):1243-52. Review. French.
[Pharmacological bases of intraperitoneal chemotherapy] Gladieff L, Chatelut E, Dalenc F, Ferron G. Bull Cancer. 2009 Dec ;96(12):1235-42. Review. French.
5-Substituted [1]pyrindine derivatives with antiproliferative activity. Kolb S, Goddard ML, Loukaci A, Mondésert O, Ducommun B, Braud E, Garbay C. Eur J Med Chem. 2009 Dec 5. PMID : 19969400
[Management of advanced epithelial cancer of the ovary : towards a change in practice ?] Leblanc E, Narducci F, Querleu D, Morice P. Bull Cancer. 2009 Dec ;96(12):1149-50. French.
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. Legrand-Abravanel F, Colson P, Leguillou-Guillemette H, Alric L, Ravaux I, Lunel-Fabiani F, Bouviers-Alias M, Trimoulet P, Chaix ML, Hézode C, Foucher J, Fontaine H, Roque-Afonso AM, Gassin M, Schvoerer E, Gaudy C, Roche B, Doffoël M, D’Alteroche L, Vallet S, Baazia Y, Pozzetto B, Thibault V, Nousbaum JB, Roulot D, Coppere H, Poinard T, Payan C, Izopet J. J Med Virol. 2009 Dec ;81(12):2029-35.PMID : 19856464
Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients : results of the PACS 01 economic study. Marino P, Siani C, Roché H, Protière C, Fumoleau P, Spielmann M, Martin AL, Viens P, Le Corroller Soriano AG. Ann Oncol. 2009 Dec 27. PMID : 20038515
[Etiology and outcome of liver granulomatosis : A retrospective study of 21 cases.] Martin-Blondel G, Camara B, Selves J, Robic MA, Thebault S, Bonnet D, Alric L. Rev Med Interne. 2009 Dec 3. French. PMID : 19962798
Synthesis of new alkylaminooxysterols with potent cell differentiating activities : identification of leads for the treatment of cancer and neurodegenerative diseases. de Medina P, Paillasse MR, Payré B, Silvente-Poirot S, Poirot M. J Med Chem. 2009 Dec 10 ;52(23):7765-77.
French recommendations on the management of invasive cervical cancer during pregnancy. Morice P, Narducci F, Mathevet P, Marret H, Darai E, Querleu D ; French Working Group on Gynecological Cancers in Pregnancy ; Société Française d’Oncologie Gynécologique (SFOG) ; Société Française de Chirurgie Pelvienne (SFCP) ; Collège National des Gynécologues Obstétriciens Français (CNGOF). Int J Gynecol Cancer. 2009 Dec ;19(9):1638-41.
Association of neutrophil count with microembolization in patients with symptomatic carotid artery stenosis. Nasr N, Ruidavets JB, Arnal JF, Sie P, Larrue V. Atherosclerosis. 2009 Dec ;207(2):519-23.
[Towards a new standard in cytoreductive surgery for advanced ovarian cancer] Querleu D, Gladieff L, Ferron G, Rougé P. Bull Cancer. 2009 Dec ;96(12):1175-82. Review. French.
[Quality control criteria in the surgical management of advanced ovarian cancers] Querleu D, Narducci F. Bull Cancer. 2009 Dec ;96(12):1255-62. Review. French.
Publié le 05-01-2010